日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections

美国多中心儿科患者头孢他啶/阿维巴坦疗效评价:耐药革兰氏阴性菌感染治疗的真实世界见解

Morrisette, Taylor; Stimes, Grant T; Alvira-Arill, Gustavo R; Lockowitz, Christine R; Yuenger, Valerie; Facer, Evan E; Huang, Alex; Holger, Dana J; Althubyani, Ali A; El Ghali, Amer; Kesner, Jacob; Kufel, Wesley D; Santevecchi, Barbara A; Venugopalan, Veena; Olney, Katie B; Newland, Jason G; Shelley, Jamee; Walsh, Lauren; Wilson, William S; Dassner, Aimee M; Gainey, Andrew B; Lueking, Richard; Patterson, Logan; Mediwala Hornback, Krutika; Thacker, Stephen A

Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients

单克隆抗体疗法治疗儿童COVID-19的安全性和耐受性

Mak, Gregory; Dassner, Aimee M; Hammer, Benjamin M; Hanisch, Benjamin R

One Size Fits All? Application of Susceptible-Dose-Dependent Breakpoints to Pediatric Patients and Laboratory Reporting

一刀切?将易感剂量依赖性断点应用于儿科患者和实验室报告

Nielsen, Lindsey E; Forrester, Jeanne B; Girotto, Jennifer Ellis; Dassner, Aimee M; Humphries, Romney

In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients

头孢洛扎/他唑巴坦单独使用或与氨基糖苷类药物联合使用对儿童囊性纤维化患者多重耐药铜绿假单胞菌的体外活性

Dassner, Aimee M; Sutherland, Christina; Girotto, Jennifer; Nicolau, David P